Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PATIS: Perfusion and Antihypertensive Therapy in Acute Ischemic Stroke
NCT02327793Phase 2Completed
- Sponsor
- University of Alberta
- Start
- Jun 2009
- Primary completion
- Jul 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label trial of nitroglycerin and labetalol in ischemic stroke (3 arms), sponsored by University of Alberta. Primary endpoint: Change in Volume of Hypoperfused Tissue. Started Jun 2009; status: completed.
02
Drugs
nitroglycerinlabetalol
03
Conditions
ischemic stroke
Beyond the preview
Go deeper on NCT02327793.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02327793.